Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Windlas Biotech IPO.
August 4, 2021 3:30:00 AM
Windlas Biotech IPO opens on August 4 and closes on August 6. Demat account, trading application and UPI ID are mandatory if you are applying for an initial public offering (IPO). Windlas Biotech ...
Published by : Business Insider IndiaAugust 20, 2021 12:46:00 AM
In a three-day IPO, Windlas Biotech was subscribed 22.46 times on the final day, the offer was opened on August 4 and closed on August 6, 2021. The IPO received bids for 13,77,39,750 shares against 61 ...
Published by : Zee BusinessJuly 1, 2024 2:30:00 PM
Biopharma deal activity plummeted down to Earth in the second quarter, with just a handful of M&A transactions and IPOs studding the mostly dark skies. | The slow quarter follows an exciting first one ...
Published by : FierceBiotechJune 28, 2024 8:32:00 AM
In the latest sign that biotech�s return to the public markets remains somewhat lackluster, Alumis has downsized its IPO as the company prepares to list on the Nasdaq this morning. The biotech ...
Published by : FierceBiotechJune 28, 2024 5:35:00 AM
The twisty IPO may say more about investor appetite for biotech companies � even those with drugs in late-stage clinical trials � than it does about South San Francisco-based Alumis itself.
Published by : The Business JournalsJune 28, 2024 1:45:00 PM
Alumis, an immunology drug developer on the cusp of Phase 3, will go public Friday in a smaller IPO than it originally projected. The Bay Area startup sold 13.12 million shares $ALMS at $16 apiece to ...
Published by : ENDPOINTS NEWSApril 23, 2024 8:06:00 PM
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! After a two-year dry spell, initial public offerings by biotech companies showed ...
Published by : MSNJune 28, 2024 1:44:00 PM
The offering is expected to close on 1 July. Earlier this month, the US-based biotech said that it planned to use part of the IPO proceeds to advance its lead asset ESK-001 into multiple Phase III ...
Published by : Yahoo FinanceOctober 12, 2023 9:50:00 PM
After a decade of significant challenges, biotech's long-term sustainability depends on making fundamental changes to its traditional business model. A commonly held perception in the biotech ...
Published by : NatureJune 24, 2024 3:47:00 PM
New York-based LB Pharmaceuticals is preparing to file for an initial public offering as investor and pharma enthusiasm grows for the neuroscience space, a source familiar with the company's plans ...
Published by : ENDPOINTS NEWSJune 24, 2024 3:30:00 AM
It would be the first Bay Area biotech IPO since February, when Kyverna Therapeutics Inc.'s $336.2 million net offering capped a micro-flurry of offerings. That wave included Metagenomi Inc. of ...
Published by : The Business JournalsMay 5, 2023 3:30:00 AM
The company raised $540 million from the sale of 30 million shares at $18 apiece, in the largest biotech IPO in the US since Sana Biotech went public in early 2021 with a $588 million raise that ...
Published by : pharmaphorumThe IPO Shares of Windlas Biotech Limited IPO are proposed to list on Monday, August 16, 2021 at BSE, NSE. The public issue of Windlas Biotech IPO was opened on Aug 4, 2021 and closed for subscription on Aug 6, 2021. Windlas Biotech IPO Listing Date and Information:
| Listing Date | Monday, August 16, 2021 |
| BSE Script Code | 543329 |
| NSE Symbol | WINDLAS |
| Listing In | |
| ISIN | INE0H5O01029 |
| Issue Price | ₹460 Per Equity Share |
| Face Value | ₹5 Per Equity Share |
The allotment status of Windlas Biotech Limited IPO is now available online. The public issue of Windlas Biotech IPO was open on Aug 4, 2021 and closed for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE.
The issue of Windlas Biotech Limited opens on Aug 4, 2021 and closes for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 448- Rs 460 Per Equity Share.
Windlas Biotech Limited is entering in the capital market with an IPO of [.] Equity Shares of Rs 5 aggregating up to Rs 401.54 Crore. The price for the issue has been set at Rs 448-460 Rs Per Equity Share.
Incorporated in 2001, Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.
The issue opens on Aug 4, 2021 and closes for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE.
The Windlas Biotech IPO is proposed to open on August 4, 2021. The IPO application ends on August 6, 2021.
Retail investors can apply in the retail or non-institutional investor category from August 4, 2021 to August 6, 2021. The Windlas Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Windlas Biotech IPO will open for subscription on August 4, 2021. The public issue will close on August 6, 2021.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
